Search details
1.
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
PLoS Pathog
; 13(5): e1006368, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28467485
2.
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
PLoS Pathog
; 12(1): e1005381, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26795282
3.
Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome.
J Infect Dis
; 216(9): 1159-1163, 2017 11 27.
Article
in English
| MEDLINE | ID: mdl-29040604
4.
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.
J Infect Dis
; 216(7): 813-818, 2017 10 17.
Article
in English
| MEDLINE | ID: mdl-28968888
5.
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.
HIV Clin Trials
; 15(4): 133-9, 2014.
Article
in English
| MEDLINE | ID: mdl-25143022
6.
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
Arterioscler Thromb Vasc Biol
; 33(2): 387-92, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23202367
7.
A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects.
AIDS Res Ther
; 11: 14, 2014.
Article
in English
| MEDLINE | ID: mdl-24904682
8.
Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
J Virol
; 86(10): 5719-29, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22398281
9.
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
PLoS Pathog
; 12(3): e1005540, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-27015639
10.
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.
J Infect Dis
; 206(11): 1715-23, 2012 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23002445
11.
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.
J Infect Dis
; 205(9): 1443-7, 2012 May 01.
Article
in English
| MEDLINE | ID: mdl-22454462
12.
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
J Virol
; 85(21): 11422-34, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21880771
13.
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
J Virol
; 84(19): 10354-65, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20668079
14.
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
J Virol
; 84(21): 11020-9, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20719952
15.
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
Blood
; 113(17): 3978-89, 2009 Apr 23.
Article
in English
| MEDLINE | ID: mdl-19109229
16.
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.
J Infect Dis
; 201(12): 1796-805, 2010 Jun 15.
Article
in English
| MEDLINE | ID: mdl-20446847
17.
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
J Infect Dis
; 201(11): 1686-96, 2010 Jun 01.
Article
in English
| MEDLINE | ID: mdl-20420510
18.
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet
; 374(9692): 796-806, 2009 Sep 05.
Article
in English
| MEDLINE | ID: mdl-19647866
19.
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).
AIDS Res Ther
; 7: 30, 2010 Aug 05.
Article
in English
| MEDLINE | ID: mdl-20687947
20.
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
Clin Infect Dis
; 48(3): 350-61, 2009 Feb 01.
Article
in English
| MEDLINE | ID: mdl-19123865